Temozolomide
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma (NCT05512481) | Peking University Cancer Hospital & Institute | 2022-09-13 |
| Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma (NCT06279767) | The First Affiliated Hospital with Nanjing Medical University | 2022-07-01 |
| Trial in Low Grade Glioma Patients: Wait or Treat (NCT03763422) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-03-16 |
| TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors (NCT03079440) | Asan Medical Center | 2017-05-15 |
Track Temozolomide automatically
Every clearance here is in the API, with alerts when new ones post.